This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sato Pharmaceutical Co., Ltd.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Innovations of Yoshiki Itoh in Pharmaceutical Chemistry
Introduction
Yoshiki Itoh is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Yoshiki Itoh holds a total of four patents. His latest patent focuses on a difluoromethylene compound that exhibits URAT1 inhibitory activity. This compound serves as an URAT1 inhibitor, a blood uric acid level-reducing agent, and is part of a pharmaceutical composition. The invention is specifically represented by a formula that outlines its chemical structure and potential applications.
Career Highlights
Throughout his career, Yoshiki Itoh has been associated with Sato Pharmaceutical Co., Ltd. His work has been instrumental in advancing the understanding and treatment of conditions related to uric acid levels in the blood.
Collaborations
Yoshiki Itoh has collaborated with notable colleagues, including Keita Nagai and Koh Nagasawa. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Yoshiki Itoh's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile